Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes - Mantovani, A; Turino, T; Lando, M G (Diabetes Metab, 2020)
et al.